07.11.2012 • NewsHospiraQ3 2012sales and profits

Hospira Posts Quarterly Profit Vs Year-Ago Loss

Hospira on Wednesday posted a net profit for the third quarter compared with a year-earlier loss as sales rose slightly, and backed its outlook for the full year.

Net earnings were $1.2 million, or 1 cent per share, versus a net loss of $88.9 million, or 54 cents per share, in the 2011 quarter.

Excluding items, earnings were 47 Cents per share. On that basis, analysts on average were expecting earnings of 45 cents.

Sales rose 1.8% to $994.0 million from $976.7 million a year before.

Hospira, a maker of specialty injectable pharmaceuticals and drug pumps, said it continues to expect 2012 net sales to show a fall of 1% to a rise of 2%, excluding the impact of foreign currency.

It forecast full-year earnings per share, excluding items, of $2.00.

 

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.